{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+samples+collected&page=65", "query": { "intervention": "Blood samples collected", "page": 65 }, "page_size": 10 }, "pagination": { "page": 65, "page_size": 10, "total_count": 4263, "total_pages": 427, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+samples+collected&page=66&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Blood+samples+collected&page=64&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T14:42:58.672Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05010109", "title": "Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Locally Advanced Lung Non-Small Cell Carcinoma", "Stage III Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8" ], "interventions": [ { "name": "6 Minute Walk Functional Test", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Exercise Cardiac Stress Test", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Single Photon Emission Computed Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2021-07-05", "completion_date": "2027-02-02", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05010109" }, { "nct_id": "NCT02549716", "title": "Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Subarachnoid Hemorrhage", "Stroke" ], "interventions": [ { "name": "IV acetaminophen", "type": "DRUG" }, { "name": "Oral acetaminophen", "type": "DRUG" }, { "name": "Oral placebo", "type": "DRUG" }, { "name": "IV placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3, "start_date": "2017-01-05", "completion_date": "2018-06-08", "has_results": true, "last_update_posted_date": "2019-04-10", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 1, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02549716" }, { "nct_id": "NCT01148563", "title": "Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Congestive Heart Failure" ], "interventions": [ { "name": "Tele-health Monitoring", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Pennington Biomedical Research Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 136, "start_date": "2009-03", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2024-01-25", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 4, "location_summary": "Baton Rouge, Louisiana • Houma, Louisiana • Lafayette, Louisiana + 1 more", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Houma", "state": "Louisiana" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "Lake Charles", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01148563" }, { "nct_id": "NCT02026934", "title": "CliniMACS® CD34+ Reagent System for Expanded Access Use", "overall_status": "NO_LONGER_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Graft-Versus-Host Disease(GVHD)", "Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells", "Graft Failure", "Delayed Graft Function" ], "interventions": [ { "name": "CliniMACS CD34 Reagent System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Joseph Antin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2013-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-11-21", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02026934" }, { "nct_id": "NCT02003209", "title": "Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HER2-Positive Breast Carcinoma", "Hormone Receptor-Positive Breast Carcinoma", "Stage IB Breast Cancer AJCC v7", "Stage IIA Breast Cancer AJCC v6 and v7", "Stage IIB Breast Cancer AJCC v6 and v7", "Stage IIIA Breast Cancer AJCC v7", "Stage IIIB Breast Cancer AJCC v7", "Stage IIIC Breast Cancer AJCC v7" ], "interventions": [ { "name": "Aromatase Inhibition Therapy", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cytology Specimen Collection Procedure", "type": "OTHER" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Goserelin Acetate", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Pertuzumab", "type": "BIOLOGICAL" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Therapeutic Conventional Surgery", "type": "PROCEDURE" }, { "name": "Trastuzumab", "type": "BIOLOGICAL" }, { "name": "Whole Breast Irradiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "OTHER", "BIOLOGICAL", "PROCEDURE", "RADIATION" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 315, "start_date": "2014-02-18", "completion_date": "2025-06-30", "has_results": true, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 731, "location_summary": "Fairbanks, Alaska • Hot Springs, Arkansas • Anaheim, California + 466 more", "locations": [ { "city": "Fairbanks", "state": "Alaska" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Antioch", "state": "California" }, { "city": "Arroyo Grande", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02003209" }, { "nct_id": "NCT00500734", "title": "Cardiomyopathy Tissue Bank in a Cancer Population", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heart Disease" ], "interventions": [ { "name": "Blood Sample", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": null, "sex": "ALL", "summary": "2 Months and older" }, "enrollment_count": 1000, "start_date": "2002-12-10", "completion_date": "2020-12", "has_results": false, "last_update_posted_date": "2020-01-27", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00500734" }, { "nct_id": "NCT05197621", "title": "The Impact of COVID-19 on Maternal and Neonatal Outcomes", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COVID-19", "Pregnancy; Infection" ], "interventions": [ { "name": "mRNA COVID-19 vaccine (Pfizer or Moderna)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "14 Years to 55 Years · Female only" }, "enrollment_count": 300, "start_date": "2020-04-13", "completion_date": "2028-05-05", "has_results": false, "last_update_posted_date": "2026-05-11", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05197621" }, { "nct_id": "NCT05044936", "title": "Topical Cannabidiol Cream and Post-exercise Recovery", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Muscle Damage" ], "interventions": [ { "name": "Cannabidiol Oil", "type": "DRUG" }, { "name": "Resistance Exercise", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 0, "start_date": "2023-05-15", "completion_date": "2023-05-15", "has_results": false, "last_update_posted_date": "2023-05-17", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT05044936" }, { "nct_id": "NCT05471011", "title": "COVID-19 Outcome Prediction Algorithm", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "COVID-19", "Post Acute Sequelae of COVID-19", "Long COVID", "Organ Dysfunction Syndrome, Multiple", "Frailty Syndrome" ], "interventions": [ { "name": "Blood and nasal swab sampling", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2022-08-08", "completion_date": "2026-05-31", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 7, "location_summary": "Los Angeles, California • Sylmar, California • Torrance, California + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sylmar", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Decatur", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05471011" }, { "nct_id": "NCT01869634", "title": "Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Human Immunodeficiency Virus Infection" ], "interventions": [ { "name": "darunavir with ritonavir and fixed-dose viread+emtricitabine daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 37, "start_date": "2013-06", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2020-03-04", "last_synced_at": "2026-10-18T14:42:58.672Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01869634" } ] }